# Neoadjuvant Chemotherapy Versus Radiochemotherapy for Cancer of the Esophagus or Cardia

> **NCT01362127** · PHASE2 · COMPLETED · sponsor: **Karolinska University Hospital** · enrollment: 181 (actual)

## Conditions studied

- Carcinoma, Squamous Cell
- Adenocarcinoma of the Esophagus and Gastric Cardia

## Interventions

- **DRUG:** Chemotherapy
- **RADIATION:** Radiochemotherapy

## Key facts

- **NCT ID:** NCT01362127
- **Lead sponsor:** Karolinska University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2013-06
- **Final completion:** 2018-06-25
- **Target enrollment:** 181 (ACTUAL)
- **Last updated:** 2020-02-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01362127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01362127, "Neoadjuvant Chemotherapy Versus Radiochemotherapy for Cancer of the Esophagus or Cardia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01362127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*